生物及臨床檢測用納米抗體/Nanobodies for Biotechnology and Clinical Diagnostics - 北京協同創新研究院
新聞動態 | 黨群建設 | 聯系我們
首頁 / / 生物及臨床檢測用納米抗體/Nanobodies for Biotechnology and Clinical Diagnostics
生物及臨床檢測用納米抗體/Nanobodies for Biotechnology and Clinical Diagnostics

       納米抗體是小型化的抗體,可在科研中標記純化目標蛋白、臨床診斷中進行免疫診斷。本項目將構建納米抗體開發平臺,實現成果批量轉化。     

       ?體積小,親水,耐熱耐酸堿,性能穩定易保存 

       ?結構簡單,易生物合成,生產成本低

       ?化學性質靈活,與抗原結合力強,檢測靈敏度高

       A nanobody is a single domain antibody; it can be used to label or purify target proteins in biomedical research, and in immunohistochemistry during clinical diagnosis. The market size for breast cancer diagnosis is up to 200 million CNY. This project will lead to a nanobody R&D platform and realize its commercialization in batches.

       ?Light-weight, hydrophilic, thermal/pH stable, long shelf life with stable performance

       ?Simple structure, easy to synthesize, low cost

       ?Flexible chemical characteristics, strong binding affinity to antigens, and high sensitivity in assays

letou体育国米 体育赛事| 体育下注| 赛事直播| 体育网址| 德甲| 竞猜APP| 在线直播| 法甲| 体育网址| NBA| 法甲| 体育在线| NBA| 欧冠|